News Channels

03 Jan 2023 Chemomab Reports Top-Line Results from CM-101 Phase 2a Liver Fibrosis Biomarker Trial in NASH Patients
03 Jan 2023 ProfoundBio Announces Initiation of First-in-Human Trial for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Receives FDA "Study May Proceed" Letter for PRO1160, a CD70-Directed ADC
03 Jan 2023 Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies
02 Jan 2023 Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products Enabled by Alteogen’s Hybrozyme™ Technology
02 Jan 2023 Alligator Bioscience Announces Positive Interim Results from Mitazalimab OPTIMIZE-1 Phase 2 Trial in Pancreatic Cancer Exceeding 50% Objective Response Rate
29 Dec 2022 TransCode Therapeutics Announces FDA Authorization to Proceed with First-In-Human Clinical Trial
29 Dec 2022 Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults
29 Dec 2022 Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate
28 Dec 2022 SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Nirogacestat for the Treatment of Adults with Desmoid Tumors
28 Dec 2022 Deka Biosciences, Inc Announces Submission of Investigational New Drug (IND) Application for Lead Oncology Asset, DK210 (EGFR)
28 Dec 2022 PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates
28 Dec 2022 PeptiDream Announces New Research and Collaboration Agreement with Lilly for the Discovery of Novel Peptide Drug Conjugates
28 Dec 2022 Janux Therapeutics Announces Submission of Investigational New Drug Application for JANX008, an EGFR-TRACTr for Solid Tumors
28 Dec 2022 U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
28 Dec 2022 TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)
27 Dec 2022 BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
24 Dec 2022 Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
24 Dec 2022 LegoChem Biosciences and Amgen Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates
24 Dec 2022 Ipsen receives Complete Response Letter for palovarotene, an investigational treatment for fibrodysplasia ossificans progressiva
23 Dec 2022 UCB Announces FDA Acceptance of BLA Resubmission for Bimekizumab

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up